Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma

Regional Lymph Node Classification for Lung Cancer Staging

Clifton F. Mountain, Carolyn M. Dresler · CHEST Journal · 1997 · 1.4K citations

Medicine, Oncology, Surgery +14

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial

Harm van Tinteren, Otto S. Hoekstra, Egbert F. Smit et al. · The Lancet · 2002 · 864 citations

Medicine, Nuclear Medicine, Oncology +14

Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use

Wolfgang Weber, Volker Petersen, Burkhard Schmidt et al. · Journal of Clinical Oncology · 2003 · 504 citations

Medicine, Nuclear Medicine, Oncology +17

Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer

Michael P. Mac Manus, Rodney J. Hicks, Jane Matthews et al. · Journal of Clinical Oncology · 2003 · 449 citations

Medicine, Nuclear Medicine, Oncology +17

Prognostic Importance of the Standardized Uptake Value on ¹⁸F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases

Johan Vansteenkiste, Sigrid Stroobants, Patrick Dupont et al. · Journal of Clinical Oncology · 1999 · 439 citations

Medicine, Nuclear Medicine, Oncology +17